Cargando…

Chronic diseases among vitiligo patients: A case control study

OBJECTIVES: To identify the proportion and risk of chronic diseases in vitiligo patients in a tertiary hospital in Riyadh, Kingdom of Saudi Arabia (KSA). METHODS: A retrospective case-control study included 61 vitiligo patients and 61 normal non-dermatology controls in King Abdulaziz Medical City, R...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Houssien, Abdullah O., Al Houssien, Rana O., Al Ajroush, Waleed, Al Kahtani, Hassan S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Saudi Medical Journal 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5447193/
https://www.ncbi.nlm.nih.gov/pubmed/28397947
http://dx.doi.org/10.15537/smj.2017.4.17551
_version_ 1783239272997847040
author Al Houssien, Abdullah O.
Al Houssien, Rana O.
Al Ajroush, Waleed
Al Kahtani, Hassan S.
author_facet Al Houssien, Abdullah O.
Al Houssien, Rana O.
Al Ajroush, Waleed
Al Kahtani, Hassan S.
author_sort Al Houssien, Abdullah O.
collection PubMed
description OBJECTIVES: To identify the proportion and risk of chronic diseases in vitiligo patients in a tertiary hospital in Riyadh, Kingdom of Saudi Arabia (KSA). METHODS: A retrospective case-control study included 61 vitiligo patients and 61 normal non-dermatology controls in King Abdulaziz Medical City, Riyadh, KSA between January and September 2016. Age, gender and co-morbid diseases including hypertension, diabetes, dyslipidemia, obesity and hypothyroidism were retrieved from participants’ charts and medical records. Proportion and mean were used to describe the variables, and odds ratio (OR) was used to test the data. RESULTS: A total of 122 participants (34 males, 88 females) equally divided in cases and controls. The mean age was 45±19 years for the case and 40±17 years for the control group. The proportion of diabetes (51%) was higher in the case group than the control (33%) (OR: 0.47; 95% confidence interval [CI]: 0.23-0.98; p=0.04). Dyslipidemia was significantly associated with vitiligo (67%) compared with the control group (48%) (OR: 0.44; 95% CI: 0.21-0.92; p=0.03). Vitiligo participants had a significantly increased risk of having hypothyroidism (26%) compared with the control group (10%) (OR: 0.31; 95% CI: 0.11-0.85; p=0.02). CONCLUSION: There is an increased risk of chronic diseases among vitiligo patients including diabetes, dyslipidemia, hypothyroidism, renal injuries, and obesity.
format Online
Article
Text
id pubmed-5447193
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Saudi Medical Journal
record_format MEDLINE/PubMed
spelling pubmed-54471932017-06-02 Chronic diseases among vitiligo patients: A case control study Al Houssien, Abdullah O. Al Houssien, Rana O. Al Ajroush, Waleed Al Kahtani, Hassan S. Saudi Med J Original Article OBJECTIVES: To identify the proportion and risk of chronic diseases in vitiligo patients in a tertiary hospital in Riyadh, Kingdom of Saudi Arabia (KSA). METHODS: A retrospective case-control study included 61 vitiligo patients and 61 normal non-dermatology controls in King Abdulaziz Medical City, Riyadh, KSA between January and September 2016. Age, gender and co-morbid diseases including hypertension, diabetes, dyslipidemia, obesity and hypothyroidism were retrieved from participants’ charts and medical records. Proportion and mean were used to describe the variables, and odds ratio (OR) was used to test the data. RESULTS: A total of 122 participants (34 males, 88 females) equally divided in cases and controls. The mean age was 45±19 years for the case and 40±17 years for the control group. The proportion of diabetes (51%) was higher in the case group than the control (33%) (OR: 0.47; 95% confidence interval [CI]: 0.23-0.98; p=0.04). Dyslipidemia was significantly associated with vitiligo (67%) compared with the control group (48%) (OR: 0.44; 95% CI: 0.21-0.92; p=0.03). Vitiligo participants had a significantly increased risk of having hypothyroidism (26%) compared with the control group (10%) (OR: 0.31; 95% CI: 0.11-0.85; p=0.02). CONCLUSION: There is an increased risk of chronic diseases among vitiligo patients including diabetes, dyslipidemia, hypothyroidism, renal injuries, and obesity. Saudi Medical Journal 2017-04 /pmc/articles/PMC5447193/ /pubmed/28397947 http://dx.doi.org/10.15537/smj.2017.4.17551 Text en Copyright: © Saudi Medical Journal http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Al Houssien, Abdullah O.
Al Houssien, Rana O.
Al Ajroush, Waleed
Al Kahtani, Hassan S.
Chronic diseases among vitiligo patients: A case control study
title Chronic diseases among vitiligo patients: A case control study
title_full Chronic diseases among vitiligo patients: A case control study
title_fullStr Chronic diseases among vitiligo patients: A case control study
title_full_unstemmed Chronic diseases among vitiligo patients: A case control study
title_short Chronic diseases among vitiligo patients: A case control study
title_sort chronic diseases among vitiligo patients: a case control study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5447193/
https://www.ncbi.nlm.nih.gov/pubmed/28397947
http://dx.doi.org/10.15537/smj.2017.4.17551
work_keys_str_mv AT alhoussienabdullaho chronicdiseasesamongvitiligopatientsacasecontrolstudy
AT alhoussienranao chronicdiseasesamongvitiligopatientsacasecontrolstudy
AT alajroushwaleed chronicdiseasesamongvitiligopatientsacasecontrolstudy
AT alkahtanihassans chronicdiseasesamongvitiligopatientsacasecontrolstudy